AtriCure Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $42.39
- Today's High:
- $43.63
- Open Price:
- $43
- 52W Low:
- $32.51
- 52W High:
- $52.96
- Prev. Close:
- $43.09
- Volume:
- 307218
Company Statistics
- Market Cap.:
- $2.22 billion
- Book Value:
- 9.628
- Revenue TTM:
- $349.30 million
- Operating Margin TTM:
- -9.82%
- Gross Profit TTM:
- $245.94 million
- Profit Margin:
- -10.81%
- Return on Assets TTM:
- -3.67%
- Return on Equity TTM:
- -8.23%
Company Profile
AtriCure Inc had its IPO on 2005-08-05 under the ticker symbol ATRC.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. AtriCure Inc has a staff strength of 1,050 employees.
Stock update
Shares of AtriCure Inc opened at $43 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $42.39 - $43.63, and closed at $43.45.
This is a +0.84% increase from the previous day's closing price.
A total volume of 307,218 shares were traded at the close of the day’s session.
In the last one week, shares of AtriCure Inc have slipped by -4.94%.
AtriCure Inc's Key Ratios
AtriCure Inc has a market cap of $2.22 billion, indicating a price to book ratio of 4.5361 and a price to sales ratio of 6.2592.
In the last 12-months AtriCure Inc’s revenue was $349.30 million with a gross profit of $245.94 million and an EBITDA of $-22515000. The EBITDA ratio measures AtriCure Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, AtriCure Inc’s operating margin was -9.82% while its return on assets stood at -3.67% with a return of equity of -8.23%.
In Q1, AtriCure Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 25.4%.
AtriCure Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- -1.18
Its diluted EPS in the last 12-months stands at $-0.87 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -1.18. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into AtriCure Inc’s profitability.
AtriCure Inc stock is trading at a EV to sales ratio of 6.1179 and a EV to EBITDA ratio of -50.2409. Its price to sales ratio in the trailing 12-months stood at 6.2592.
AtriCure Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $583.10 million
- Total Liabilities
- $62.47 million
- Operating Cash Flow
- $28.81 million
- Capital Expenditure
- $2.50 million
- Dividend Payout Ratio
- 0%
AtriCure Inc ended 2024 with $583.10 million in total assets and $0 in total liabilities. Its intangible assets were valued at $583.10 million while shareholder equity stood at $454.85 million.
AtriCure Inc ended 2024 with $0 in deferred long-term liabilities, $62.47 million in other current liabilities, 47000.00 in common stock, $-333095000.00 in retained earnings and $234.78 million in goodwill. Its cash balance stood at $77.34 million and cash and short-term investments were $135.86 million. The company’s total short-term debt was $10,677,000 while long-term debt stood at $51.94 million.
AtriCure Inc’s total current assets stands at $238.33 million while long-term investments were $25.56 million and short-term investments were $58.52 million. Its net receivables were $45.66 million compared to accounts payable of $23.56 million and inventory worth $48.85 million.
In 2024, AtriCure Inc's operating cash flow was $28.81 million while its capital expenditure stood at $2.50 million.
Comparatively, AtriCure Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $43.45
- 52-Week High
- $52.96
- 52-Week Low
- $32.51
- Analyst Target Price
- $59.8
AtriCure Inc stock is currently trading at $43.45 per share. It touched a 52-week high of $52.96 and a 52-week low of $52.96. Analysts tracking the stock have a 12-month average target price of $59.8.
Its 50-day moving average was $50.28 and 200-day moving average was $45.42 The short ratio stood at 5.52 indicating a short percent outstanding of 0%.
Around 271.6% of the company’s stock are held by insiders while 9955.7% are held by institutions.
Frequently Asked Questions About AtriCure Inc
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula’s to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.